Diabetes and COVID-19: Role of insulin resistance as a risk factor for COVID-19 severity

doi:10.4239/wjd.v12.i9.1550

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6449)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

511

WORD

201

HTML

4339

Figures (1-2)

138

Tables (1-1)

145

Sum=5334

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

426

Download

689

Sum=1115

Sep 15, 2021 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (18)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Diabetes. Sep 15, 2021; 12(9): 1550-1562
Published online Sep 15, 2021. doi: 10.4239/wjd.v12.i9.1550

Full Size Figure Download Figure

Figure 1 Insulin resistance may act as a bridging link between coronavirus disease 2019 and diabetes. The potential mechanism by which insulin resistance mediates coronavirus disease 2019 (COVID-19) severity is through angiotensin converting enzyme 2 protein, systemic inflammation, pancreatic β cell damage, and thrombosis. The potential markers of insulin resistance for evaluating diabetes status in patients with COVID-19 are also mentioned. CRP: C-reactive protein; CT: Computed tomography; IL-6: Interleukin-6; IR: Insulin receptor; MRI: Magnetic resonance imaging; T2DM: Type 2 diabetes mellitus.

Citation: Gangadharan C, Ahluwalia R, Sigamani A. Diabetes and COVID-19: Role of insulin resistance as a risk factor for COVID-19 severity . World J Diabetes 2021; 12(9): 1550-1562
URL: https://www.wjgnet.com/1948-9358/full/v12/i9/1550.htm
DOI: https://dx.doi.org/10.4239/wjd.v12.i9.1550